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Summary
 
Members of the nuclear factor (NF)-
 
k
 
B/Rel family transcription factors are induced during
thymic selection and in mature T lymphocytes after ligation of the T cell antigen receptor
(TCR). Despite these findings, disruption of individual NF-
 
k
 
B/Rel genes has revealed no in-
trinsic defect in the development of mature T cells, perhaps reflecting functional redundancy.
To circumvent this possibility, the T cell lineage was targeted to express a 
 
trans
 
-dominant form
of I
 
k
 
B
 
a
 
 that constitutively represses the activity of multiple NF-
 
k
 
B/Rel proteins. Transgenic
cells expressing this inhibitor exhibit a significant proliferative defect, which is not reversed by
the addition of exogenous interleukin-2. Moreover, mitogenic stimulation of splenocytes leads
to increased apoptosis of transgenic T cells as compared with controls. In addition to deregu-
lated T cell growth and survival, transgene expression impairs the development of normal T cell
populations as evidenced by diminished numbers of TCR
 
hi
 
 CD8 single-positive thymocytes.
This defect was significantly amplified in the periphery and was accompanied by a decrease in
CD4
 
+
 
 T cells. Taken together, these in vivo findings indicate that the NF-
 
k
 
B/Rel signaling
pathway contains compensatory components that are essential for the establishment of normal
T cell subsets.
 
N
 
uclear translocation of members of the nuclear factor
(NF)-
 
k
 
B
 
1
 
/Rel transcription factor family is activated
in thymocytes and mature T lymphocytes after engagement
of the TCR (1–4). The prototypic form of NF-
 
k
 
B is a het-
erodimeric complex containing NF-
 
k
 
B1 (p50) or NF-
 
k
 
B2
(p52), either of which may combine with a 
 
trans
 
-activating
subunit. The major 
 
trans
 
-activating subunits of NF-
 
k
 
B that
are induced during T cell activation are c-Rel and RelA
(p65) (5). In quiescent T lymphocytes, these various forms
of NF-
 
k
 
B are sequestered in the cytoplasm by virtue of
their association with a set of inhibitory proteins that in-
cludes I
 
k
 
B
 
a
 
 (6, 7). During normal T cell activation, I
 
k
 
B
 
a
 
is rapidly degraded via the ubiquitin–proteasome pathway,
thus permitting the nuclear import of NF-
 
k
 
B (6, 7). Bind-
ing sites for NF-
 
k
 
B have been found in many genes in-
volved in T cell effector function, including those that en-
code regulatory cytokines and receptors (5). These findings
raise the possibility that NF-
 
k
 
B regulates homeostatic mecha-
nisms in the T lineage, such as those involved in cell cycle
control or programmed cell death. Moreover, NF-
 
k
 
B is in-
duced in developing thymocytes through interactions with
stromal cells and during thymic selection (4, 8). Taken to-
gether, these in vitro studies suggest an important role for
NF-
 
k
 
B/Rel proteins in the development of mature T cells.
Despite these findings, mice deficient for individual NF-
 
k
 
B/Rel subunits exhibit no intrinsic defect in the establish-
ment of normal populations in the T lineage (9–14). For
example, p50-deficient mice express a normal number and
distribution of T cells (9). Although mice lacking the RelA
subunit of NF-
 
k
 
B die in utero, progenitor cells derived
from these animals give rise to a normal T cell repertoire
(10, 11). Targeted disruption of the gene encoding RelB, a
constitutively expressed member of the NF-
 
k
 
B/Rel family,
leads to a profound reduction in APCs rather than an in-
trinsic defect in the T lineage (12, 13). In contrast, c-Rel–
deficient T cells are impaired in their ability to produce the
growth factor IL-2, resulting in decreased proliferation in
response to mitogens. Despite this proliferative effect, T cell
development in c-Rel
 
2/2
 
 mice appears unaffected (14).
These unexpected findings have raised unresolved ques-
tions concerning whether NF-
 
k
 
B plays any significant role
in the generation of mature T cells (15). However, all of
these gene disruption experiments are complicated by the
 
1
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k
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potential for functional redundancy. Indeed, prior in vitro
studies have shown that complexes containing either c-Rel
or RelA have the potential to stimulate transcription from
the same promoter (16, 17).
To circumvent this critical issue of functional redun-
dancy, we targeted to the T lineage a 
 
trans
 
-dominant form
of I
 
k
 
B
 
a
 
 under tissue-specific control of the proximal lck
promoter (18, 19). This inhibitor, termed l
 
k
 
B
 
a
 
(
 
D
 
N), lacks
sequences required for signal-dependent degradation and
functions as a constitutive repressor of multiple NF-
 
k
 
B/Rel
proteins in transfected B and T lymphocytes (6, 7, 18, 20).
Consistent with these in vitro studies, signal-dependent in-
duction of the c-Rel and RelA 
 
trans
 
-activating subunits of
NF-
 
k
 
B was profoundly impaired in transgenic thymocytes.
This dual block in the NF-
 
k
 
B/Rel signaling pathway was
associated with (
 
a
 
) a proliferative defect that is refractory to
IL-2, (
 
b
 
) increased sensitivity of T cells to apoptosis after
mitogenic stimulation, and (
 
c
 
) an abnormal distribution of
T cell subsets. Taken together, these findings demonstrate
that NF-
 
k
 
B plays a significant role in the development and
homeostatic control of mature T cells.
 
Materials and Methods
 
Production of Transgenic Mice Expressing I
 
k
 
B
 
a
 
(
 
D
 
N).
 
The cDNA
encoding an NH
 
2
 
-terminally truncated form of human I
 
k
 
B
 
a
 
(amino acids 37–317) fused to the FLAG epitope (18) was cloned
into p1017–lck (20). An SpeI fragment encompassing this tissue-
specific transcription unit was isolated by agarose gel electro-
phoresis and micro-injected (Transgenic Core Facility, Vanderbilt
Cancer Center, Nashville, TN) into the pronuclei of C57BL/6 
 
3
 
DBA/2 zygotes together with a BamHI–XbaI fragment contain-
ing the locus control region from the human CD2 gene (21).
Mice were maintained in accordance with federal and state gov-
ernment regulations after institutional approval. Four indepen-
dent founders with both fragments integrated in the germline
were crossed with C57BL/6 mice for these studies. Northern blot
analysis of organ RNAs and immunoblotting with purified B cells
confirmed the T lineage specificity of transgene expression (data
not shown).
 
Antibodies and Fluorochrome-conjugated Reagents.
 
Polyclonal anti-
bodies specific for RelA were obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA). The c-Rel–specific antiserum was pro-
vided by Dr. N. Rice (National Cancer Institute, Bethesda, MD).
Rabbit antisera generated against amino acids 289–317 of human
I
 
k
 
B
 
a
 
 have been described (18). Fluorochrome-conjugated anti-
bodies against TCR-
 
ab
 
 (Cy-Chrome), CD3 (r-PE), CD4 (r-PE),
CD8
 
a
 
 (FITC or r-PE), CD25 (FITC), CD45R/B220 (FITC),
CD69 (FITC), and H-2K
 
b
 
 (FITC) were obtained from PharMin-
gen (San Diego, CA) or GIBCO BRL (Gaithersberg, MD). Avi-
din and streptavidin–FITC were obtained from PharMingen.
 
Cell Preparation.
 
Single cell suspensions from thymus, spleen,
and lymph node were prepared by crushing the organs in com-
plete media (RPMI-1640 supplemented with 10% fetal bovine
serum, 2 mM 
 
l
 
-glutamine, and 0.1% penicillin–streptomycin)
followed by hypotonic lysis of erythrocytes. PBLs were purified
from heparinized blood by density gradient centrifugation on Fi-
coll–HyPaque (22). Splenic T lymphocytes were depleted of B
cells by chromatography through nylon wool columns, followed
by panning on immobilized antibodies against mouse IgM (22,
23). In brief, single cell suspensions from pooled spleens were
 
added to preequilibrated nylon wool columns in RPMI-1640
supplemented with 5% fetal bovine serum at 37
 
8
 
C. After 45 min
at 37
 
8
 
C, the nonadherent cells were eluted from the column into
plastic Petri dishes (Fisher Scientific) coated with goat anti–mouse
IgM (10 
 
m
 
g/ml) and goat IgG (40 
 
m
 
g/ml) to remove residual B
lymphocytes. The resultant population was 
 
,
 
10% B220
 
1
 
 and
75–90% T cells as determined by flow cytometry.
 
Immunoprecipitations and Western Blot Analyses.
 
Cytosolic extracts
were prepared from single cell suspensions cultured in the pres-
ence or absence of PMA (50 ng/ml) and ionomycin (1 
 
m
 
M) for
30 min using published methods (18), except that the detergent
lysis buffer was supplemented with a mixture of protease inhibi-
tors (24). Where indicated, the translation inhibitor cyclohexi-
mide was added at 50 
 
m
 
g/ml for 30 min before stimulation. Ly-
sates were clarified by centrifugation and equilibrated in ELB
buffer (50 mM 
 
N
 
-2-hydroxyethylpiperazine-
 
N
 
9
 
-2-ethanesulfonic
acid [Hepes] pH 7.0, 250 mM NaCl, 5 mM EDTA, 1 mM
dithiothreitol, and 0.1% NP40). Immunoprecipitations were per-
formed on cytoplasmic extracts (500 
 
m
 
g) using 20 
 
m
 
l of agarose
beads coupled to antibodies specific for either RelA, c-Rel, or the
FLAG epitope. After three washes with ELB buffer, proteins were
either eluted with cognate peptide (RelA, FLAG) or SDS, frac-
tionated by SDS-PAGE, and transferred to polyvinylidene difluo-
ride membranes (Dupont/NEN Life Science, Wilmington, DE).
Membranes were blocked (1 h at room temperature) with Tris-
buffered saline containing 0.1% Tween-20 and 5% powdered
milk (BLOTTO), then incubated with a rabbit antiserum specific
for I
 
k
 
B
 
a
 
. Immunoreactive polypeptides were detected with don-
key anti–rabbit IgG conjugated to horseradish peroxidase using
enhanced chemiluminescence (Dupont).
 
Gel Shift Analysis and DNA–Protein Cross-linking.
 
Nuclear frac-
tions were prepared from single cell suspensions by high-salt ex-
traction in the presence of protease inhibitors (18). Gel mobility
shift assays were performed by using a 
 
32
 
P-labeled oligonucleotide
duplex derived from 
 
k
 
B enhancer sequences in the IL-2 receptor
 
a
 
 promoter (
 
k
 
B-pd) (5
 
9
 
-CAACGGCAGGGGAATTCCCCT-
CTCCTT-3
 
9
 
) (24). DNA-binding reaction mixtures (20 
 
m
 
l)
contained 4 
 
m
 
g of nuclear extract, 2 
 
m
 
g double-stranded poly (dI–
dC), and 10 mg BSA buffered in 20 mM Hepes (pH 7.9), 5%
glycerol, 1 mM EDTA, 1% NP40, and 5 mM dithiothreitol. Re-
sultant nucleoprotein complexes were resolved on a native 5%
polyacrylamide gel and visualized by autoradiography (25). For
DNA–protein cross-linking analysis, photoreactive derivatives of
the radiolabeled kB probe were synthesized in the presence of
5-bromo-29-deoxyuridine triphosphate (BrdUTP). DNA bind-
ing reaction mixtures were irradiated at 300 nm for 30 min using
a Fotodyne UV transilluminator, diluted to 200 ml with ELB buf-
fer, and immunoprecipitated with the indicated Rel-specific anti-
bodies and protein A–agarose (20 ml). Immune complexes were
washed three times in ELB buffer, heat denatured in SDS sample
buffer, resolved by SDS-PAGE, and detected by autoradiography.
Quantitation of IL-2 in Culture Supernatants. Production of IL-2
was measured by ELISA of supernatants from thymocytes and sple-
nocytes after mitogenic stimulation. The ELISAs were performed
using plates precoated with anti-mouse IL-2 according to the in-
structions of the manufacturer (Endogen, Boston, MA). IL-2 lev-
els were quantitated by comparison to standards supplied by the
manufacturer.
Proliferation Assays. Thymocyte suspensions were counted
and plated (2 3 105 cells per 100 ml of media) in microtitre wells
pretreated overnight with either PBS or anti-CD3 mAb (10 mg/ml)
(145-2C11, PharMingen; or 29B, GIBCO BRL). Triplicate sam-
ples were cultured for 48 h at 378C in the presence of PMA and1899 Boothby et al.
ionomycin or Con A (2.5 mg/ml). Tritiated thymidine (1 mCi in
100 ml of media) was added to each well for the final 8 h before
determination of radioisotope incorporation into DNA. To quan-
titate T cell proliferation, pooled spleen and lymph node suspen-
sions were depleted of B cells and macrophages by chromatogra-
phy through nylon wool columns, then used in proliferation
assays, as above, in the presence or absence of an activating ham-
ster mAb against mouse CD28 (10 mg/ml; PharMingen, clone
37.51). To distinguish the proliferative capacity of lymphoblasts
from small lymphocytes, splenocytes were cultured for 40 h in the
absence or presence of Con A (2.5 mg/ml) and then treated for 1 h
with 5-bromo-29-deoxyuridine (BrdU; 100 mM). Fractions of
BrdU-positive CD41 or CD81 cells were measured as described
(26). In brief, after staining with either anti-CD4–rPE or anti-
CD8–rPE, cells were permeabilized with 95% EtOH, fixed with
paraformaldehyde, and treated with 50 U of DNase I (Boehringer-
Mannheim Biochemicals, Indianapolis, IN). After a 10 min incu-
bation at room temperature, cells were stained with a FITC-con-
jugated mAb against BrdU (Beckton-Dickinson, Mountain View,
CA) and analyzed by flow cytometry. Significant BrdU uptake
was restricted to cells in the lymphoblast gate as determined by
relative light-scattering characteristics (data not shown).
TdT-mediated dUTP–Biotin Nick End Labeling (TUNEL) Assays
and Indirect Immunofluorescence. Surface staining of single cell sus-
pensions was performed using optimized concentrations of fluo-
rochrome-conjugated purified mAbs (0.25 mg per 106 cells) (27).
Samples of 1–2 3 104 cells were analyzed using a FACScanÒ Plus
flow cytometer (Beckton-Dickinson, Mountain View, CA) with
uniform gates and quadrants. To generate samples for quantitative
TUNEL assays, single cell suspensions were cultured in the pres-
ence of either Con A (2.5 mg/ml) or immobilized anti-CD3 mAb
(10 mg/ml). After 40 h of culture, cells were harvested and frac-
tions were stained with PE-conjugated mAb against CD4 or CD8
(PharMingen). To perform TUNEL assays, PE-stained cells were
fixed with paraformaldehyde and permeabilized with 70% EtOH
at 2208C. After washing in PBS supplemented with 1% BSA
(PBS/BSA), cells were resuspended in reaction mixtures contain-
ing terminal deoxynucleotidyl transferase (TdT; GIBCO BRL) and
biotin–16–dCTP (Boehringer-Mannheim Biochemicals). After in-
cubation at 378C for 30 min, cells were washed in PBS/BSA,
stained with FITC-conjugated avidin, and analyzed by flow cy-
tometry (28). Control reactions lacking TdT were performed to
generate a background profile for assessment of nonspecific stain-
ing. For restimulation experiments (29), pooled spleen and lymph
node cell suspensions were depleted of B cells and macrophages
by chromatography through nylon wool columns, cultured for 24 h
in the presence of Con A (5 mg/ml), washed with methyl-a-d-
mannoside (10 mg/ml), then incubated in complete media con-
taining IL-2 (100 mm/ml) for an additional 24 h. Viable cells
were recovered by fractionation on Ficoll–HyPaque step density
gradients and replated (5 3 105 cells/ml) in the presence of im-
mobilized anti-CD3 antibodies (0.005–0.5 mg/ml) or mouse
TNF-a (1 or 50 ng/ml; R&D Systems, Minneapolis, MN). Cell
death was then quantitated using forward light scatter and 7-amino
actinomycin D staining characteristics, as described (29).
Results
Inhibition of Nuclear c-Rel and RelA Activity in T Lineage
Cells. The induced trans-activation of NF-kB–responsive
genes in the T lineage is mediated primarily by c-Rel and
RelA (reviewed in 5–7). Prior in vitro studies have shown
that c-Rel and RelA have the capacity to activate transcrip-
tion from an overlapping set of promoters (16, 17), thus
suggesting compensatory functions. To bypass the potential
for functional redundancy, we created transgenic mice ex-
pressing a truncated form of IkBa that is refractory to sig-
nal-induced degradation (18). Transgene expression was
specifically targeted to the T lineage using the proximal lck
promoter (20), thus facilitating studies to assess the role of
the NF-kB/Rel signaling pathway in mouse T lineage cells.
Four founder lines expressing this constitutive repressor,
termed IkBa(DN), were classified as Tglo (n 5 2) or Tghi (n 5
2) based upon the magnitude of transgene expression. The
IkBa(DN) protein was readily detected in both thymus
and spleen from transgenic mice, albeit at different apparent
steady-state levels in these unfractionated cell populations
(Fig. 1 A, lanes 3 and 6). Importantly, this difference was
negligible when immunoblotting experiments were per-
formed with comparable numbers of T lineage cells from
each organ (data not shown).
To determine whether the IkBa(DN) protein integrated
into the endogenous NF-kB/Rel signaling pathway, co-
immunoprecipitation studies were performed with Rel-
specific antisera. These experiments revealed the presence
of IkBa(DN) in latent NF-kB/Rel complexes containing
the transactivating subunits c-Rel (data not shown) and RelA
(Fig. 1 B). Levels of the endogenous form of IkBa associ-
ated with RelA were dramatically decreased; however, pro-
longed exposure of the immunoblots revealed residual
amounts of this inhibitor (Fig. 1 B, lane 3; data not shown).
In contrast with wild-type IkBa (Fig. 1 B, lanes 1 and 2),
IkBa(DN) was resistant to degradation in thymocytes treated
with PMA and ionomycin (lanes 3 to 6), a combination
that mimics activation through the TCR. To investigate
the integrity of the NF-kB/Rel signaling pathway, mobil-
ity shift analyses were performed with nuclear extracts from
cells treated with PMA and ionomycin. Under these stimu-
latory conditions, wild-type but not Tghi thymocytes ex-
pressed high levels of nuclear NF-kB/Rel activity (Fig. 1 C,
lanes 2 and 6), whereas thymocytes from Tglo animals ex-
pressed intermediate levels of nuclear NF-kB (lane 4). In
addition to being dose-dependent, the observed signaling
defect was selective, in that induction of AP-1 activity and
c-jun RNA was unimpaired in transgenic thymocytes (data
not shown).
To investigate the subunit composition of the affected
complexes, we performed DNA–protein cross-linking ex-
periments. These studies revealed a striking decrease in nu-
clear RelA and c-Rel in extracts from Tghi mice as com-
pared with nontransgenic (NTg) controls (Fig. 1 D, lanes 2
and 6). Similar results were obtained using antibodies spe-
cific for c-Rel and RelA in supershift analyses (data not
shown). In keeping with these results using Tghi thymo-
cytes, nuclear expression of inducible NF-kB complexes
was also decreased in splenic T cells from Tghi mice when
compared with NTg controls (Fig. 1 E, lanes 6 and 8).
Taken together, these findings indicate that IkBa(DN) spe-1900 Role of Rel Complexes in T Cell Development and Homeostasis
cifically represses signal-dependent activation of nuclear
RelA and c-Rel, which are normally induced during thy-
mic selection and T cell activation (4, 8, 30).
Decreased IL-2 Production by Transgenic Thymocytes and T
Cells. Prior in vitro studies have suggested a central role
for NF-kB/Rel proteins in transcriptional regulation of
the IL-2 gene (31, 32). Consistent with these findings, IL-2
production is impaired in T cells derived from c-Rel–defi-
cient mice (14). Considering the inhibitory effects of
IkBa(DN) on c-Rel DNA binding activity, we next inves-
tigated whether IL-2 gene expression was compromised in
transgenic thymocytes. For these studies, thymocytes from
Tghi mice and their NTg littermates were cultured in the
absence or presence of PMA and ionomycin, followed by
ELISA to quantitate the concentration of IL-2 secreted into
culture supernatants. As shown in Fig. 2, wild-type thy-
mocytes produced 14,100 pg/ml of IL-2, reflecting at least
a 3,000-fold increase in cytokine expression relative to the
basal level. In contrast, IL-2 production by comparable
numbers of activated Tghi thymocytes was drastically re-
duced to 645 pg/ml. In companion studies, we found that
IL-2 production by mitogen-stimulated Tghi splenocytes
was also attenuated relative to controls (8% of control; data
not shown). These findings demonstrate that the block im-
posed on the DNA binding activities of c-Rel and RelA
(see Fig. 1) is associated with a profound deficit in IL-2
Figure 1. Abrogated expres-
sion of NF-kB/Rel in IkBa(DN)
transgenic mice. (A) Transgene-
encoded IkBa expressed in
thymocytes and splenocytes. Cy-
toplasmic extracts from unfrac-
tionated cell suspensions were
subjected to immunopurification
using immobilized anti-FLAG M2
antibodies and resolved by SDS-
PAGE. Resolved proteins were
transferred to polyvinylidene dif-
luoride membranes and probed
with an antiserum directed
against human IkBa (amino ac-
ids 289–317) in conjunction
with an enhanced chemilumines-
cence detection system (Amer-
sham Corp., Arlington Heights,
IL) (18). NTg, nontransgenic;
Tglo, low expressor; Tghi, high
expressor. (B) Assocation of en-
dogenous IkBa (E) and trans-
gene-encoded IkBa ( D N) with
the RelA subunit of NF-kB. Iso-
lated thymocytes from the indi-
cated sources were cultured for
0.5 h in the presence of cyclo-
heximide (50 mg/ml) to arrest
translation and then treated with
PMA and ionomycin for 0.5 h as
indicated. Proteins were immunoprecipitated from cytosolic extracts using a RelA-specific
antiserum and subjected to immunoblot analysis as in A. Similar results were obtained after
immunoprecipitation with c-Rel–specific antibodies (data not shown). (C) Gel mobility
shift analysis of nuclear NF-kB/Rel proteins. Thymocyte suspensions were prepared from
the indicated sources and cultured for 0.5 h in the presence or absence of PMA/ionomy-
cin. Equal amounts of nuclear extracts were added to DNA binding mixtures containing a
32P-labeled kB probe (kB-pd) (24). DNA–protein complexes were resolved on nondena-
turing polyacrylamide gels and visualized by autoradiography. (D) DNA–protein cross-
linking assay of nuclear NF-kB/Rel proteins. DNA binding reaction mixtures (as in C)
were irradiated with UV light, fractionated by SDS-PAGE, and visualized by autoradiog-
raphy (lanes 1–6) (18, 24, 25). Alternatively, portions of reaction mixtures generated for
lane 2 were subjected to immunoprecipitation using the indicated antiserum before gel
electrophoresis (lanes 7–9). Subunit identities are indicated. (E) Gel mobility shift analysis
of nuclear NF-kB/Rel proteins in splenic T cells. B cell–depleted T cell populations
(,10% B2201; .80% CD31) were prepared from splenocytes pooled from three NTg
and four Tghi mice. Cells were cultured for 1 h in the presence or absence of PMA/iono-
mycin (lanes 5–8) in parallel with resting and stimulated thymocytes pooled from the same
mice (lanes 1–4). Equal amounts of nuclear extracts were added to DNA binding mixtures
containing a 32P-labeled kB probe (kB-pd) (24). DNA–protein complexes were resolved
on nondenaturing polyacrylamide gels and visualized by autoradiography. The major induc-
ible complexes (p50–RelA and p50–c-Rel) are indicated with an arrow; the constitutive,
higher mobility complexes consist of p50 homodimers (30).1901 Boothby et al.
production, thus establishing the presence of a significant
functional defect in the NF-kB/Rel signaling pathway that
affects the expression of downstream genes.
Inhibition of Growth Signal Transduction by IkBa(DN).
Prior studies have shown that c-Rel–deficient T cells de-
velop normally but exhibit impaired mitogenic responses (14).
This proliferative defect was fully reversed by exogenous
IL-2 (14). Evidence of a transgene-dependent block in IL-2
production by Tghi thymocytes led us to investigate their
proliferative response to the T cell mitogens Con A, com-
binations of PMA and ionomycin, or immobilized anti-
body to the TCR (anti-CD3). As shown in Fig. 3, Tghi
thymocytes manifested a dramatic decrease in the prolifera-
tion induced by each of these mitogens (A–C; control). We
reasoned that this growth defect might be attributed to the
20-fold difference in IL-2 concentrations in these cultures
(see Fig. 2). However, as shown in Fig. 3 A addition of ex-
ogenous IL-2 to Tghi thymocytes failed to restore prolifera-
tion to normal levels. Similar results were obtained with
unfractionated (data not shown) or B cell–depleted spleno-
cytes (Fig. 3 D). These results are in sharp contrast with
those obtained using c-Rel–deficient mice (14), presum-
ably reflecting an additional contribution by RelA (Fig. 1 D).
In this regard, there was a 50% decrease in the frequency of
T cells positive for IL-2Ra chain (CD25), which has in its
59-flanking DNA a site for RelA/p50 binding (5, 33).
However, Tghi-derived cells that were able to undergo blast
transformation and enter S phase expressed normal levels of
CD25 (data not shown). We conclude that the failure of
exogenous IL-2 to restore normal proliferation of Tghi T
cells is likely due to the reduced expression of a compe-
tence factor other than the IL-2Ra chain.
Enhanced Apoptosis of Rel-arrested T Cells After Activa-
tion. It is now well recognized that programmed cell
death can occur in response to primary stimulation through
the TCR (34–36) or after activated T cells are exposed to
certain proapoptotic agents (37). Moreover, evidence from
studies with established cell lines suggests that NF-kB may
either inhibit (38, 39) or enhance their susceptibility to apop-
tosis (40–42). Accordingly, we next investigated the influ-
ence of IkBa(DN) transgene expression on entry into the
apoptotic pathway after primary activation of resting T cells
with mitogens. When the prevalence of apoptotic T cells
was determined by TUNEL assays after mitogenic stimu-
lation with Con A, we observed that expression of the
IkBa(DN) transgene led to a two-fold increase in the fre-
quency of T cell apoptosis (Fig. 4 A). This enhancement in
programmed cell death applied to both CD41 and CD81
T cells. Similar results were obtained using immobilized anti-
TCR antibodies as the stimulus, albeit with a more pro-
nounced effect on the CD81 subset (Fig. 4 B). Selective
gating on lymphoblasts revealed a doubling in the fre-
quency of apoptotic CD81 T cells derived from the trans-
genic mice as compared with controls. Thus, the increased
sensitivity to apoptosis observed under these experimental
conditions cannot be attributed solely to the failure of these
cells to undergo blast transformation. We conclude that the
expression of IkBa(DN) in transgenic T cells is associated
with enhanced apoptosis of T cells in response to primary
TCR stimulation (35, 36).
IkBa(DN) Perturbs Development of Mature T Cell Lineages.
In contrast with c-Rel–deficient mice, our results with
IkBa(DN) transgenic animals demonstrate a proliferative
defect that is refractory to IL-2, as well as enhanced T cell
apoptosis. These novel defects raised the possibility that es-
tablishment of T cell populations might be abnormal in
IkBa(DN) transgenic mice. To investigate this possibility,
we first measured the prevalence of CD4 and CD8 single-
positive (SP) cells among thymocytes. Thymic cellularity
was unaffected by the transgene and FACSÒ profiles indi-
cated normal frequencies of CD42CD82 and CD41CD81
thymocytes (Fig. 5 A). Thus, despite significant inhibition
of NF-kB/Rel activity (see Fig. 1 C), TCR a and b chain
gene rearrangement proceed normally, as does the expan-
sion of immature thymocytes to the double-positive stage
(43). In contrast, Tghi CD8 SP thymocytes bearing high
levels of TCR-ab were decreased 40% relative to NTg
controls (P ,0.0001), whereas TCRhi CD4 SP cells were
unaffected (Fig. 5 B). There was no difference in the stain-
ing intensity for CD8 present on any thymocyte subset,
which excludes the possibility that IkBa(DN) downregu-
lated the CD8 gene. Furthermore, expression of the class I
MHC antigen Kb on Tghi thymocytes and splenocytes was
normal, as were mRNA levels for the H-2K antigen. As
such, the observed decrease in CD8 SP cells does not ap-
pear to be due to inadequate class I MHC expression (44,
45). Given that the TCRhi subset of thymocytes is associ-
ated with repertoire selection (46), we conclude that T cell
development in the thymus of Tghi mice is partially im-
paired.
Figure 2. IL-2 production by thymocytes from IkBa(DN) transgenic
mice. Thymocytes from either NTg or Tghi mice were cultured in tripli-
cate for 48 h in media alone (open bars) or treated with combinations of
PMA (50 ng/ml) and ionomycin (1 mg/ml) (stippled bars). Supernatants
from these cultures and IL-2 standards were assayed by ELISA. IL-2 pro-
duction by unstimulated NTg thymocytes was below the detection limit of
the assay (3–5 pg IL-2/ml). Results represent the mean values (6 SEM)
from five separate Tghi mice and five NTg littermates, as analyzed in three
separate experiments.1902 Role of Rel Complexes in T Cell Development and Homeostasis
While T cell subsets are established during the differenti-
ation of immature precursors in the thymus, the ultimate
outcome of T cell development is the establishment of nor-
mal populations in the periphery (47). To investigate fur-
ther the significance of NF-kB/Rel proteins in this process,
we measured the prevalence of T cells in spleen, lymph
node, and blood. As shown in Fig. 6 A, T cell numbers
were significantly reduced at each of these peripheral sites
in Tghi animals as compared with NTg littermates. With re-
spect to mature T cell subsets, CD81 T cells were substan-
tially decreased in the periphery of Tghi animals relative to
controls (Fig. 6 B). A significant loss of CD41 cells was also
Figure 3. Failure of IL-2 to rescue the proliferative defect in IkBa(DN) mice. Thymocytes from either NTg (open bars) or Tghi (closed bars) mice were
treated for 40 h with (A) combinations of PMA (50 ng/ml) and ionomycin (1 mg/ml). (B) Con A (2.5 mg/ml), or (C) plate-bound anti-CD3 (10 mg/ml),
in the presence or absence of IL-2 (100 U/ml) as indicated. Cells were pulsed for an additional 8 h with tritiated thymidine and harvested for scintillation
counting. The results are shown as the mean of tritiated thymidine incorporation (6 SEM) for eight Tghi mice and eight NTg littermates (four indepen-
dent experiments). (D) Splenocytes depleted of B cells and macrophages were analyzed under similar conditions using plate-bound anti-CD3 (10 mg/ml),
agonistic antibodies against CD28 (10 mg/ml), and IL-2 (100 U/ml) as indicated.
observed in spleen and blood, although this defect was con-
sistently less severe (Fig. 6 C). Similar evidence for skewing
of CD4/CD8 ratios was obtained by gating specifically on
a/b-TCR–bearing cells in the spleen, lymph nodes, and
blood (data not shown). Thus, the asymmetric effect of
IkBa(DN) on the populations of positively selected SP cells
in the thymus is amplified in the periphery. An altered ratio
of CD4/CD8 subsets was also observed in the Tglo lines of
mice. However, consistent with the biochemical data (see
Fig.1 C), these CD81 T cells were less profoundly affected
(50% of normal numbers) relative to Tghi mice (Fig. 6, leg-
end), demonstrating a dose-dependent effect of the trans-1903 Boothby et al.
gene. Because endogenous IkBa is still present in this
transgenic system (see Fig.1 B), our results may underesti-
mate the quantitative significance of NF-kB/Rel proteins
in determining T cell levels. Notwithstanding this uncer-
tainty, these findings provide strong in vivo evidence that
an intact NF-kB/Rel signaling pathway is essential for ac-
quisition of a normal proportion of CD81 T cells.
Discussion
Since its original discovery in B cells, NF-kB has been
widely implicated in the transcriptional control of genes in-
volved in T cell activation and growth (5). This signal
transduction pathway is tightly coupled to the TCR and is
induced during selection of double-positive thymocytes (1–
4, 8). Despite these findings, mice deficient for p50, c-Rel,
or RelB have a normal number and distribution of T cell
subsets (9–14), thus raising questions concerning the signif-
icance of NF-kB/Rel proteins in the establishment and main-
tenance of a normal T cell compartment (15). However,
these gene disruption experiments are complicated by the
potential for functional redundancy and, as shown for RelA,
can lead to early embryonic lethality (10). To circumvent
these technical problems, we targeted to the T lineage a
truncated form of IkBa that constitutively represses the nu-
clear expression of multiple NF-kB dimers. When expressed
in transgenic thymocytes, this modified inhibitor dramati-
cally attenuated nuclear import of RelA and c-Rel (Fig.
1, C and D). These two Rel-related polypeptides represent
the principal trans-activating subunits of NF-kB that are in-
duced in response to TCR ligation (1, 5, 8, 30). Based on
these biochemical findings, we investigated whether simul-
taneous arrest of RelA and c-Rel in the T cell compart-
ment is associated with novel phenotypic alterations relative
to those reported in prior gene targeting studies.
Figure 4. Increased apoptosis among activated T cells from IkBa(DN)
transgenic mice. (A) Splenocytes from either NTg (open bars) or Tghi
(closed bars) mice were cultured in the presence of Con A (2.5 mg/ml).
After 40 h in culture, cells were divided equally, stained with PE-labeled
antibodies against CD4 or CD8, and subjected to TUNEL analysis. The
data represent the mean percentage (6 SEM) of TUNEL-positive cells in
each T cell subset. The mean was calculated using data from 19 individual
Tghi mice or an equal number of NTg controls (10 independent experi-
ments with 6–8-wk-old mice). The increased frequencies of apoptotic
cells among transgenic CD41 and CD81 cells were statistically significant
when compared with nontransgenic CD41 or CD81 cells (P ,0.001).
(B) Splenocytes were activated using plate-bound anti-CD3, then pro-
cessed for TUNEL assays as in A. Results represent cumulative data from
12 individual Tghi mice or an equal number of NTg controls (six inde-
pendent experiments with 6-8-wk-old mice). The increased frequencies
of apoptotic cells among transgenic CD41 and CD81 cells were statisti-
cally significant when compared with nontransgenic CD41 or CD81 cells
(P <0.001).
Figure 5. Decreased thymic CD81 cells in IkBa(DN) transgenic mice. (A) A representative FACSÒ profile from three-color indirect immuno-
fluorescence experiments. Thymocytes from NTg and Tghi mice were analyzed by flow cytometry for surface expression of CD4 and CD8 on cells bear-
ing high density TCR-a/b (TCR high) or medium to low density receptors (TCR med/low). Gating of cells based on TCR-a/b expression is shown to
the left, together with the percentage of total cells in each gate. Dual parameter fluorescence histograms (CD4 versus CD8) derived from the gated subsets
(TCRmed/lo and TCRhi, respectively) are shown on the right. Numbers represent the percentage of gated thymocytes in each quadrant. Mean cell counts
were equivalent in NTg and Tghi thymuses (99 [6 9.1] 3 106 versus 97.7 [6 10.1] 3 106 respectively). (B) Subset distribution of the TCRhi thymocyte
populations in NTg (open bars) and Tghi (closed bars) mice. Mean cell populations (6 SEM) or TCRhi cells in the CD41 CD82 and CD42 CD81 quad-
rants are shown (n 5 10). There was no significant difference in mean numbers of CD42 CD82 or CD41 CD81 cells.1904 Role of Rel Complexes in T Cell Development and Homeostasis
Requirement for RelA and c-Rel in IL-2-responsive Prolifera-
tion. During the process of T cell activation, nuclear
translocation of NF-kB is associated with transcriptional ac-
tivation of the genes encoding IL-2 and IL-2Ra (CD25),
which together are required for normal growth signal trans-
duction (48–50). Recent gene disruption experiments have
demonstrated that c-Rel–deficient T cells exhibit a defect
in IL-2 production, which leads to a diminished prolifera-
tive response (14). In these prior studies, exogenous IL-2
restored T cell proliferation, indicating that the IL-2 signal-
ing pathway is intact in c-Rel–deficient lymphocytes (14).
Although the mitogenic response of T lineage cells express-
ing IkBa(DN) is also impaired, we have found that this re-
sponse cannot be fully restored by exogenous IL-2. Given
the biochemical differences between the two in vivo sys-
tems, these data suggest that RelA contributes a unique
function(s) in the T cell activation program that is not com-
pensated for by c-Rel. One potential function involves the
control of IL-2Ra gene expression, which is normal in
c-Rel2/2 mice (14). Indeed, prior in vitro studies have sug-
gested that the activity of the IL-2Ra promoter is under
RelA control (51). However, we have found that T lym-
phoblasts derived from Tghi mice express normal levels of
surface IL-2Ra and that thymocytes from these animals re-
spond to IL-2–mediated growth signals, albeit at lower lev-
els. Taken together, these data suggest that T cells in our
experimental system acquire functional IL-2 receptors, thus
raising the possibility that NF-kB regulates genes important
for growth signal transduction in T cells following engage-
ment of the IL-2R (52, 53).
Enhanced Apoptosis of Activated T Cells. In addition to
growth signal transduction, prior studies have suggested
that members of the NF-kB/Rel family of proteins con-
tribute to the regulation of programmed cell death. For ex-
ample, high levels of c-Rel expression are associated with
apoptosis in the developing avian embyro and bone mar-
row cells (40). In contrast, more recent studies indicate that
NF-kB protects embryonic fibroblasts and transformed T cells
from TNF-a–induced apoptosis (38, 39). The data pre-
Figure 6. Altered T cell subsets in IkBa(DN) transgenic mice. Cells
from the indicated peripheral sites were stained with fluorochrome-con-
jugated mAbs against CD3 (A), CD8 (B), or CD4 (C) and analyzed by
flow cytometry. Mean cell counts were equivalent in NTg and Tghi
spleens (77.9 [6 7.2] versus 72.7 [6 5.0] 3 106 cells, respectively; P .0.5),
and reduced in Tghi lymph nodes (9.25 [6 1.6] 3 106 cells) relative to
NTg samples (15.0 [6 2.6] 3 106 cells; P 5 0.09). Therefore, the data are
presented as the percentage of cells (6 SEM) expressing these surface
markers in spleen (n 5 22), lymph node (n 5 11), or blood (n 5 9). Dif-
ferences between NTg (open bars) and Tghi (closed bars) samples were sig-
nificant at P ,0.0001 (spleen) and P ,0.001 (blood, lymph node) with the
exception of CD41 lymph node cells. Analysis of T cells at each of these
sites failed to reveal the CD8lo population previously linked to superanti-
gen-induced apoptosis and CD81 T cell loss (26). Evidence of T cell hy-
peractivation (50) was absent. Splenic cellularity was normal in two inde-
pendent Tglo lines (n 5 9). CD41 and CD81 cells represented 17.5 6
1.6% and 5.0 6 0.8% of Tglo splenocytes (CD4/CD8 ratio 5 4.6 6 0.9).
In contrast, CD41 and CD81 cells represented 20.1 6 1.0% and 10.0 6
0.55% of splenocytes from littermate controls. The observed differences in
CD81 cell numbers and CD4/CD8 ratios were significant at P ,0.001 and
P ,0.05, respectively.1905 Boothby et al.
sented here indicate that NF-kB can also protect primary
T lymphocytes from death after stimulation through the
TCR. These findings may be related to recent studies dem-
onstrating that CD3 stimulation leads to rapid T cell apop-
tosis in vivo (35, 36). Of note, apoptosis can also be in-
duced by secondary stimulation of T cells activated by
treatment with a mitogen and IL-2 (29, 37, 54). Consistent
with our primary stimulation data (Fig. 4), we have found
that nylon wool–purified T cells from transgenic spleens
exhibit enhanced apoptosis using this secondary stimulation
model (data not shown). However, Tghi T cells also exhibit
a proliferative defect that cannot be rescued by IL-2 (Fig.
3), a finding that complicates the interpretation of any re-
sults obtained using these latter experimental conditions.
In light of the observed steady-state decrease in Tghi T cell
populations (Fig. 6), the NF-kB–dependent mechanism of
protection described here may exert a significant influence
on lymphocyte homeostasis by inducing the expression of
one or more downstream genes that affect T cell survival.
In this regard, the expression of FasL and anti-apoptotic
gene products such as Bcl-2 and Bcl-xL has been linked to
the regulation of T cell population size (29, 35, 36, 54–58).
However, levels of Bcl-2, Bcl-x, and FasL RNA in resting
and stimulated cells from Tghi and NTg animals were com-
parable (data not shown). Prior in vitro studies have also
shown that the death of activated T cells may result from
IL-2 withdrawal or inadequate costimulation through cell
surface CD28 (54, 58, 59). However, our preliminary stud-
ies indicate that TCR-mediated apoptosis of transgenic T cells
cannot be reversed by either exogenous IL-2 or agonistic
antibodies directed against CD28 (data not shown). As such,
the mechanism by which NF-kB protects normal T cells
from TCR-induced apoptosis may involve a distinct pathway.
Role of NF-kB in T Cell Development. The thymic phase
of T cell development involves an orderly progression from
double-negative to double-positive thymocytes, which then
undergo selection and emigration. In this biologic context,
our data provide three new lines of evidence for the in-
volvement of NF-kB in T cell development. First, the
number of TCRhi CD42CD81 cells in the thymus was de-
creased, despite the unabated accumulation of immature
thymocytes. Second, mature T cell subsets were further
compromised in the periphery. Finally, an unexpected but
striking finding to emerge from these studies was an asym-
metric effect of the transgene on the deployment of CD41
and CD81 cells.
There are very few precedents for a signal transduction
pathway which preferentially potentiates development of
mature CD81 T cells (60–63). We consider it unlikely that
the observed asymmetry is due to subset-specific differ-
ences in transgene expression, because RT-PCR and im-
munoblotting experiments revealed comparable steady-state
expression of IkBa(DN) in the CD41 and CD81 lineages
(data not shown). Moreover, transgenic thymocytes exhib-
ited a dramatic reduction (.95%) in the synthesis of IL-2
(Fig. 2), which is produced almost exclusively by the CD41
CD82 subset (3, 64, 65). Consistent with this finding, we
have also found that transgenic splenocytes produce re-
duced levels of IL-2 relative to controls (8% of control; data
not shown). Finally, NF-kB induction was arrested in a
predominantly CD41 population of Tghi T cells (Fig. 1 E).
These data strongly suggest that the IkBa(DN) transgene
blocks NF-kB signaling in the CD41 T cell compartment.
Despite these findings with CD41 cells, transgene expression
led to a preferential reduction in CD81 T cell numbers in
the thymus and periphery (Figs. 5 and 6). We conclude
that the function of the NF-kB/Rel signaling pathway in
lymphocyte homeostasis may be polarized with respect to
the deployment of specific T cell subsets. Although the
mechanism involved remains unclear, one possibility is that
CD81 cells in the intact animal are more dependent on
NF-kB for protection against apoptosis (Fig. 4 B).
In summary, we have found that corepression of RelA
and c-Rel in transgenic mice leads to multiple defects in
the T lineage. Specifically, transgenic T cells expressing
IkBa(DN) exhibited decreased IL-2 production, a prolifer-
ative defect that is refractory to exogenous IL-2, and en-
hanced apoptosis following mitogenic stimulation. Whereas
the double-negative and double-positive thymocyte subsets
in these mice appeared normal, numbers of TCRhi CD8 SP
thymocytes were significantly decreased. This deficit in CD81
T cells was exacerbated in the periphery and accompanied
by a decrease in CD41 T cells and skewed CD4/CD8 ra-
tio. These findings were not apparent in prior gene target-
ing studies (9–14), thus suggesting that RelA and c-Rel
serve compensatory functions in homeostasis. Taken together,
the data provide clear evidence for the involvement of NF-
kB/Rel proteins in T lineage development. Furthermore,
the observed asymmetric population dynamics suggest that
the mechanisms controlling CD41 and CD81 T cell num-
bers may involve distinct NF-kB signaling requirements.
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